First-pass extracted concept

OPG/RANKL/TRAIL signaling system

Candidate: concept label1 source documents4 linked claims

Jump to evidence Jump to sources Jump to claims

Live refresh every 5sNext refresh in 5s

Evidence Snippets

Current research models indicate that VC likely involves signalling pathways traditionally associated with bone remodelling, such as the OPG/RANKL/TRAIL signalling system.

Evidence 1Source 1DOI PubMedprovenance

Supporting Sources

Source 1review2016Vascular PharmacologyDOI PubMed

1 evidence snippet 4 linked claims Claim 1 Claim 2 Claim 3

Linked Claims

Claim 1directional role summarysupports2016Source 1DOI PubMed

The review states that osteoprotegerin acts as a RANKL decoy receptor that blocks the pro-calcific effect of RANKL in the vasculature.

Claim 2directional role summarysupports2016Source 1DOI PubMed

The review states that RANKL promotes vascular calcification.

Claim 3directional role summarysupports2016Source 1DOI PubMed

The review states that TRAIL may exert an anti-calcific influence within the vasculature.

Claim 4mechanistic summarysupports2016Source 1DOI PubMed

The review states that current research models indicate vascular calcification likely involves signaling pathways associated with bone remodeling, including the OPG/RANKL/TRAIL system.